Alerts will be sent to your verified email
Verify EmailREKVINA LAB.
|
Rekvina Labs
|
Colinz Laboratories
|
Link Pharma Chem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-118.34 % | 4.71 % | 1.59 % |
|
5yr average Equity Multiplier
|
6.31 | 1.29 | 1.99 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.64 | 1.33 |
|
5yr Avg Net Profit Margin
|
0.0 | 5.84 % | -0.06 % |
|
Price to Book
|
0.0 | 1.32 | 0.99 |
|
P/E
|
0.0 | 25.74 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -11.59 Days | 82.44 Days |
|
Inventory Days
|
0.0 | 56.66 Days | 64.96 Days |
|
Days Receivable
|
0.0 | 42.5 Days | 72.97 Days |
|
Days Payable
|
0.0 | 89.1 Days | 84.21 Days |
|
5yr Average Interest Coverage Ratio
|
-132.32 | 11.55 | 2.35 |
|
5yr Avg ROCE
|
-100.9 % | 6.71 % | 5.35 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 7.54 % | 3.76 % |
|
5 yr average Debt to Equity
|
-0.19 | 0.07 | 0.49 |
|
5yr CAGR Net Profit
|
18.47 % | 18.95 % | n/a |
|
5yr Average Return on Assets
|
-132.46 % | 3.68 % | 0.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.3 % | 66.0 % | 51.49 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rekvina Labs
|
Colinz Laboratories
|
Link Pharma Chem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|